Goodwill  Investor Education Initiative :  GoodWill  Eagle’s Eyes!

Pharma stocks are in limelight…will be so for sometime ! Watch Gland !

Gland Pharma increases contract manufacturing of Remdesivir: Sources

Gland Pharma has increased contract manufacturing of Remdesivir, sources told. The company is now contract manufacturing remdesivir for four companies. It had started contract manufacturing remdesivir for mylan in April 2021.

Gland Pharma production has risen for remdesivir by 2.5x since April, sources added. It is expected to be producing remdesivir for government stock piling and export markets.

Seven companies are approved to manufacture remdesivir in India including  Cadila, Cipla, Mylan, Jubilant Pharmova, Syngene, Hetero Pharmaceuticals and Dr Reddy’s Labs.

Gland Pharma has declined to comment on the report. Cadila said that the Remdac production was at 15 lakh and could be ramped up to 20 lakh if required.

Gold steady as investors eye taper clues from Fed symposium

Gold prices were steady on Friday, as investors awaited Fed chief Jerome Powell’s speech later in the day at the Jackson Hole symposium after some U.S. central bank officials called for paring bond purchases.

For all your investment needs feel free to reach us. Give us a missed call at 90037 90027. For Support : 044-40329999.

Leave a reply:

Your email address will not be published.

Site Footer

© 2018 GOODWILL - ALL RIGHTS RESERVED